Alzheimer’s changed the couple’s routine, but not their fight to keep going. Together, David and Pamela are awareness advocates for the Alzheimer’s Association. They’ve met with representatives on ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...

The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...

Along with an Alzheimer’s diagnosis comes a flood of questions, both for the person with the disease and their family. The uncertainty of a future with Alzheimer’s is ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...

November is Alzheimer's Awareness Month and 7 News met Grand Island couple Tom and Michele Drabik, who shared their experience with the disease.

Researchers have developed a simple model system that can be used to break down fibrils -- the cause of numerous disorders including Alzheimer's and Parkinson's disease -- into their constituent ...

Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.